Literature DB >> 25259654

Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms.

Xin Gao1, Hengyan Qu, Chun-Zhi Ai, Yun-Feng Cao, Ting Huang, Jian-Xing Chen, Jia Zeng, Xiao-Yu Sun, Mo Hong, Frank J Gonzalez, Zeyuan Liu, Zhong-Ze Fang.   

Abstract

1.Endogenous compounds have been reported to be the regulators of UDP-glucuronosyltransferases (UGTs) isoforms. This study aims to investigate the regulatory effects of the activity of UGT isoforms by two important lipid components phosphatidylcholine (PC) and lysophosphatidylcholines (LPC) using in vitro incubation system. 2.UGTs supersomes-catalyzed 4-methylumbelliferone (4-MU) glucuronidation was used as the probe reaction to evaluate the inhibition of compounds towards UGT isoforms except UGT1A4, and UGT1A4-catalyzed trifluoperazine (TFP) glucuronidation reaction was utilized to phenotype the activity of UGT1A4. 3.About 50 μM of LPC15:0, LPC16:0, LPC17:0, LPC18:0, LPC18:1 and PC16:0, 2:0 exhibited inhibition towards more than 90% activity of UGT isoforms, and other LPC and PC components showed negligible inhibitory potential towards all the UGT isoforms. UGT1A6 and UGT1A8 were identified to be the most sensitive UGT isoforms susceptible for the inhibition by LPC15:0, LPC16:0, LPC17:0, LPC18:0, LPC18:1 and PC16:0, 2:0, indicating the strong influence of these LPC and PC components towards UGT1A6 and UGT1A8-catalyzed metabolic reaction when the concentrations of these components increased.

Entities:  

Keywords:  Allosteric activation; UDP-glucuronosyltransferases; lysophosphatidylcholines; phosphatidylcholine

Mesh:

Substances:

Year:  2014        PMID: 25259654      PMCID: PMC6631349          DOI: 10.3109/00498254.2014.966174

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  21 in total

Review 1.  UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects.

Authors:  Karl Walter Bock; Christoph Köhle
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 2.  Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid.

Authors:  P I Mackenzie
Journal:  Ther Drug Monit       Date:  2000-02       Impact factor: 3.681

3.  Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

Authors:  Myoung Sook Han; Yu-Mi Lim; Wenying Quan; Jung Ran Kim; Kun Wook Chung; Mira Kang; Sunshin Kim; Sun Young Park; Joong-Soo Han; Shin-Young Park; Hyae Gyeong Cheon; Sang Dal Rhee; Tae-Sik Park; Myung-Shik Lee
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

Review 4.  The emerging field of lipidomics.

Authors:  Markus R Wenk
Journal:  Nat Rev Drug Discov       Date:  2005-07       Impact factor: 84.694

5.  The influence of charge and the distribution of charge in the polar region of phospholipids on the activity of UDP-glucuronosyltransferase.

Authors:  D Zakim; H Eibl
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

6.  Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.

Authors:  Verawan Uchaipichat; Peter I Mackenzie; David J Elliot; John O Miners
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

7.  Mechanism of indinavir-induced hyperbilirubinemia.

Authors:  S D Zucker; X Qin; S D Rouster; F Yu; R M Green; P Keshavan; J Feinberg; K E Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.

Authors:  Paraskevi Tsoutsikos; John O Miners; Alan Stapleton; Anthony Thomas; Benedetta C Sallustio; Kathleen M Knights
Journal:  Biochem Pharmacol       Date:  2004-01-01       Impact factor: 5.858

9.  UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.

Authors:  Judith Meza-Junco; Quincy S-C Chu; Olaf Christensen; Prabhu Rajagopalan; Soma Das; Ruslan Stefanyschyn; Michael B Sawyer
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-12       Impact factor: 3.333

Review 10.  Role of lysophosphatidylcholine (LPC) in atherosclerosis.

Authors:  Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  3 in total

1.  Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis.

Authors:  Lufang Chen; Keying Xu; Qifeng Gui; Yue Chen; Deying Chen; Yunmei Yang
Journal:  Exp Ther Med       Date:  2016-07-20       Impact factor: 2.447

2.  The odorant metabolizing enzyme UGT2A1: Immunolocalization and impact of the modulation of its activity on the olfactory response.

Authors:  Fabrice Neiers; David Jarriault; Franck Menetrier; Loïc Briand; Jean-Marie Heydel
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

3.  Transient infantile hypertriglyceridemia with jaundice: A case report.

Authors:  Jun Wang; Fang Sun; Pengfei Xu; Yufeng Zhang; Xinrong Sun; Huiling Deng
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.